In The News: Kirk Kerkorian School of Medicine at UNLV

Insider

After more than a dozen countries paused the use of AstraZeneca's coronavirus vaccine due to concerns about blood clots, the European Medicines Agency concluded on Thursday that the vaccine doesn't increase the risk of clotting.

El Tiempo

Few have made it through the first year of the COVID-19 pandemic unscathed.

KSNV-TV: News 3

After the windy arrival at Las Vegas' McCarran airport for America's second couple, and a greeting from Nevada's first couple, the first stop was to a vaccine clinic at the University of Nevada Las Vegas.

KVVU-TV: Fox 5

The expansion of Nevada's vaccine eligibility comes as welcome news to those running public vaccination sites. Sites in Clark County have had trouble filling their open appointments.

KNPR News

Nevada and the Las Vegas Medical District need additional laboratory infrastructure, and such investments would grow and diversify the economy, a new report concludes.

KNPR News

I’m sure you've seen it, pictures and videos on social media of COVID-19 vaccination cards and injections.

KNPR News

I’m sure you've seen it, pictures and videos on social media of COVID-19 vaccination cards and injections.

Las Vegas Review Journal

Thousands of vaccine appointments have gone unfilled in the past week, leading local health officials to urge opening COVID-19 vaccinations to people 55 and older.

KLAS-TV: 8 News Now

Even as more and more Nevadans get vaccinated, those who are not eligible yet feel left in the dark. That includes people with chronic health conditions.

El Tiempo

Thousands of vaccinations appointments have not been completed in the last week, prompting local health officials to call for COVID-19 vaccines to be opened to people 55 and older.

KVVU-TV: Fox 5

Sunday marked another day of more than 2 million Americans receiving the COVID-19 vaccine. The CDC will soon publish guidelines for people who are fully vaccinated.

Las Vegas Sun

Don’t skip that second shot. As Clark County awaits its first shipment of the single-dose COVID-19 vaccine manufactured by the Johnson & Johnson-owned Janssen, more than 300,000 people are halfway through their regimens of previously approved two-shot vaccines — and health officials remind them to stay the course.